Skip to Content

Resuming On-Site Research During the COVID-19 Pandemic

Microscope lit by sunlight

As part of the University of Minnesota’s Sunrise Plan to resume some operations while maintaining a safe work environment for the University community, some researchers can now receive approval to return to on-campus locations.

The new COVID-19 Guidance for the Research Community page outlines who is eligible to conduct research on-site and the steps those researchers need to follow to do so. The purpose of the plan is to strike a balance between easing restrictions to allow for research activity to resume while also implementing safety measures that keep viral transmission to a minimum.

For now, only research groups that cannot conduct their research remotely may return to their labs. Those who were deemed “Essential On-Campus” employees or who had already been approved to conduct essential research on-site do not need to seek additional approval through the Sunrise Plan process.

Anyone who falls within a group considered to be particularly vulnerable to COVID-19 (such as those with diabetes, an impaired immune system, or similar underlying conditions) are strongly encouraged to continue working from home.

To request to return to on-site work, follow the Steps for Research Resumption.

Note that certain situations—such as another statewide stay-at-home order, a spike in the rate of COVID-19 infections, or new information on how the coronavirus spreads—may require the University to quickly ramp-down research again in the future.

For previous COVID-19 research guidance, visit the Research Resources & Communications page.

For more about the Sunrise Plan overall, check the Sunrise Plan FAQs and the Faculty and Staff FAQs.

Kevin Coss

Kevin Coss

Kevin is a writer with the Office of the Vice President for Research.

coss@umn.edu

Latest Blog Posts

Dr. Friedemann-Sanchez and Dr. Grieve sitting at a table together.

In 2018, two University of Minnesota researchers traveled to a United Nations council meeting to advocate for changes to address an epidemic of violence against women in Colombia.

Read More
Senior man speaks with a health care provider while looking at a digital display

Researchers aim to help train pharmacists and educate patients with the goal of improving medication outcomes for groups with higher rates of kidney failure.

Read More
Sironix banner in a laboratory space

Sironix Renewables uses a patented method to make nontoxic, sustainably-sourced surfactants that replace their counterparts made from petroleum.

Read More
Border crossing checkpoint from Mexico to US

As an expert witness on federal immigration court cases, Patrick McNamara provides insight into violence directly and indirectly related to drug cartels.

Read More